Cho-Han Chiang

20PUBLICATIONS

55CO-AUTHORS

PharmacogenomicsCancer geneticsHaematological tumoursMolecular targetsPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|Jun 15, 2026

Semaglutide and Risk of Pancreatic Cancer: A Meta-Analysis of Randomised Trials.

|Dec 08, 2025

Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists : A Systematic Review and Meta-analysis.

Albert Ko, Yu-Cheng Chang, Furkan Bahar

|Sep 13, 2025

Impact of weight status on risk of venous thromboembolism associated with GLP-1 receptor agonists.

Cho-Han Chiang, Rushad Patell

|Aug 22, 2025

Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolism.

Sirui Ma, Yu-Cheng Chang, Cho-Han Chiang

|Feb 05, 2025

Glucagon-like peptide 1 receptor agonists and venous thromboembolism in type 2 diabetes: a target trial emulation.

Cho-Han Chiang, Junmin Song, Yu-Cheng Chang

|Jan 29, 2025

Cardiovascular outcomes and mortality in diabetic multiple myeloma patients initiated on proteasome inhibitors according to prior use of glucagon-like peptide 1 agonists.

Yu-Cheng Chang, Chun-Yu Peng, Kuan-Yu Chi

Pageof 4

Frequent Collaborators

Cho-Hung Chiang

Junmin Song

Rushad Patell

Soravis Osataphan

Kuan-Yu Chi

Yu-Che Lee

Ko-Yun Chang

Furkan Bahar

Yong Hao Yeo

Shuwen Lin

Frequent Collaborators

Cho-Hung Chiang

Junmin Song

Rushad Patell

Soravis Osataphan